The QualityStocks Daily Wednesday, July 18th, 2018

Today's Top 3 StockMarketWatch

MarketBeat (QRMLF) +200.00%

CryptoCurrencyWire (GRBX) +150.00%

QualityStocks (GTXOD) +47.98%

The QualityStocks Daily Stock List

GripeVine, Inc. (GRPV)

InvestorsHub, MarketWatch, InvestorsHangout, Morningstar, and Stockhouse reported on GripeVine, Inc. (GRPV), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

GripeVine, Inc. is a company concentrating on leading the revolution of social customer service. The Company is a proprietary complaint-resolution platform for the facilitation and management of social customer service via centralized communication, rating, and review tools. It has a highly scalable and sustainable growth model. Listed on the OTCQB, GripeVine has its headquarters in New York, New York.

GripeVine’s mission is to establish itself as a global leader in social consumer resolution and relationship management. It works to accomplish this through providing businesses strong tools to manage their social presence while providing consumers with tangible resolution results and a social engine.

High profiles companies and localized SME’s (small and medium-sized enterprises) use GripeVine. The Company speeds up the resolution process between consumers and businesses. Basically, GripeVine creates a fair space for business and consumers to interact.

GripeVine has a platform where, as the Company states, all sides can be heard. It has a user-friendly social CRM (Customer Relationship Management) platform for users to engage on. The focus is on turning negative experiences into positive outcomes.

The system incentivizes positive and amicable outcomes. Moreover, it rewards reliable consumers and responsive businesses. The emphasis is amicable or harmonious social customer service solutions for every business sector.

GripeVine provides a thriving social engine for consumers and premier back end tools for businesses. GripeVine is the next development in social customers’ relations. The Company is also the central hub of activity where businesses and consumers can be heard regarding their particular concerns.

GripeVine develops, owns, and operates social customer relations applications on desktop and mobile computing platforms. The Company has innovative patents. These patents boost a flourishing community and provide businesses first-rate control over their social public image.

In late August 2017, Mr. Richard Hue, GripeVine Chief Executive Officer, announced the launch of GripeVine.com's new platform to meet the demands of the continuing changes in the landscape of "social customer service."

Mr. Hue added, "We've also taken the opportunity to completely rebrand GripeVine with our new logo and showcasing the full capabilities of responsive flat design incorporating an entirely new UI experience that contains the complexity of robust social customer service in a simple to engage platform."

GripeVine, Inc. (GRPV), closed Wednesday's trading session at $0.179, up 19.33%, on 1,000 volume with 1 trade. The average volume for the last 60 days is 16,304 and the stock's 52-week low/high is $0.065/$0.47.

chart

Medibio Limited (MDBIF)

OTC Markets, Stockhouse, 4-Traders, InvestorsHangout, and AwesomePennyStocks reported on Medibio Limited (MDBIF), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Medibio Limited is a digital health company listed on the OTC Markets Group’s OTCQB. The Company has developed an objective testing system to assist in the screening, diagnosis, and treatment effectiveness of depression, chronic stress, and other mental health disorders. The test employs patented (and patent pending) circadian heart rate variability and cloud based proprietary algorithms to deliver a quantifiable measure to help in clinical diagnosis. Medibio is headquartered in Sydney Australia.

The Company is on course to commercialize its platform technology called the Digital Mental Health Platform. The foundation of this is on patented biomarkers from the autonomic nervous system. Medibio’s technology will provide a Diagnosis Aid to assist General Practioners (GPs) and mental health clinicians.

Regarding biomarker based objective diagnosis, a panel of circadian, sleep, and automatic system biomarkers enables automated, repeatable, and objective characterization of the impact of mental illness on the physiologic state. The Company’s Digital Mental Health Platform is a device agnostic platform that can ingest data from numerous devices. It is highly scalable, low cost, as well as easy to integrate.

Medibio’s technology provides the first objective measure of stress. It provides a series of user and corporate dashboards for assessment and wellness partner interventions.

This past July, Medibio announced the appointment of The Honourable Patrick J. Kennedy to its Board of Directors. Mr. Kennedy is a former member of the U.S. House of Representatives (D-R.I.). He is the nation’s foremost political voice on mental illness, addiction, and other brain diseases.

In addition, in July, Medibio announced the appointment of Dr. Adam Darkins, MB, ChB., MPHM, M.D., FRCS to the Board of Directors as Deputy Chairman. Dr Darkins has unique experience in taking national and trans-national virtual care delivery systems to scale.

Dr Darkins developed a wide-ranging understanding of patient care, clinical processes, and outcomes measurement from his physician training at Manchester University Medical School, UK, and more training/accreditation as a neurosurgeon and researcher at UCLA (University of California, Los Angeles).

 

Medibio Limited (MDBIF), closed Wednesday's trading session at $0.15375, up 39.77%, on 1,500 volume with 1 trade. The average volume for the last 60 days is 11,472 and the stock's 52-week low/high is $0.102/$0.36.

chart

NEMUS Bioscience, Inc. (NMUS)

Zacks, InvestorsHub, MarketWatch, Bloomberg, OTC Markets, Barron’s, Stockhouse, and TradingView reported on NEMUS Bioscience, Inc. (NMUS), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

NEMUS Bioscience, Inc. is concentrating on the discovery, development, and commercialization of cannabinoid-based therapeutics for significant unmet medical needs in worldwide markets. A highly-qualified team of executives with decades of biopharmaceutical experience and substantial background in early-stage drug development leads the Company. A biopharmaceutical company, NEMUS’ vision is to provide physicians and patients the medical benefits of "condition-specific" cannabinoids to alleviate symptoms associated with a range of diseases. NEMUS Bioscience has its headquarters in Costa Mesa, California.

The Company centers on discovering, developing, as well as commercializing new chemical entities from a class of chemically diverse compounds - cannabinoids - designed to alleviate an array of diseases and symptoms via selectively targeting CB1 and CB2 receptors. NEMUS is building a proprietary product pipeline focusing on the range from extraction processes to molecular design and inventive methods of cannabinoid drug delivery to address medical needs in the multi-billion-dollar international market opportunities.

In 2015, NEMUS Bioscience signed a research agreement with the University of Mississippi (UM). The research agreement is to study and conduct research and development (R&D) on cannabidiol (CBD) containing formulations. NEMUS, using certain proprietary technology licensed from UM, is working to develop novel ways to deliver cannabinoid-based drugs for specific indications. Its aim is optimizing the clinical effects of such drugs, while limiting the potential adverse events. Its strategy will explore the use of natural and synthetic compounds, alone or in combination.

NEMUS Bioscience has completed the validation stage of testing of its cannabinoid-based therapy undergoing development for the treatment and management of glaucoma. The therapy, NB1111, is a proprietary prodrug version of tetrahydrocannabinol (THC), which has been shown to reduce intraocular pressure (IOP) in a rabbit glaucoma model. The compound has been in-licensed from the Company’s commercial and research partner, the University of Mississippi (UM).

In May 2017, NEMUS Bioscience announced that patents were granted in Canada and Hong Kong covering its proprietary prodrug of THC, THC-valine-hemisuccinate (THCVHS), and other amide-ester forms of cannabinoid-based molecules. The patents are licensed to Nemus Bioscience by the University of Mississippi (UM). They further broaden the potential commercial territories for THCVHS. The molecule has already received patent coverage in the U.S., Japan, the UK, the EU, and Australia. THCVHS is the active pharmaceutical ingredient (API) in Nemus Bioscience’s' glaucoma drug candidate NB1111.

NEMUS Bioscience, Inc. (NMUS), closed Wednesday's trading session at $0.255, down 2.93%, on 68,300 volume with 20 trades. The average volume for the last 60 days is 82,117 and the stock's 52-week low/high is $0.10/$0.48.

chart

Regen BioPharma, Inc. (RGBP)

TopPennyStockMovers, Wall Street Mover, ProTrader, SmallCapVoice, InvestorTrendz, and TheMicrocapNews reported on Regen BioPharma, Inc. (RGBP), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Regen BioPharma, Inc. is a biotechnology company headquartered in La Mesa, California. It works to identify undervalued regenerative medicine applications in the immunotherapy and stem cell space. The Company’s aim is to speedily advance these technologies through pre-clinical and Phase I/II clinical trials. Regen BioPharma is now concentrating on checkpoint inhibitor and gene silencing therapies for treating cancer. CheckPoint Immunology, Inc. is a wholly-owned subsidiary of the Company. Formed in 2012, Regen BioPharma lists on the OTCQB.

The Company is also focusing on developing stem cell treatments for aplastic anemia. Regen is presently developing products treating blood disorders employing small molecules and gene silencing (DiffronC), and treating cancer with immunotherapy (dCellVax). In essence, Regen BioPharma is working to increase the quality of life by way of therapies involving small molecules, stem cell treatments, as well as the body's own immune system.

Furthermore, Regen is modulating important molecular processes in cancer stem cells through its patented molecular targeting approaches (BORIS). Also, the Company is repairing damaged bone marrow in patients with aplastic anemia and chemotherapy/radiotherapy treated cancer patients (HemaXellerate).

Regen BioPharma is centering on small molecules to activate and inhibit its principal target of interest, NR2F6.The Company announced in December of 2016 the filing of a [provisional/nonprovisional] utility patent application with the United States Patents and Trademark Office (USPTO) covering NR2F6-silenced CAR T cells.

Prior work demonstrated that methodologies developed by the Company and covered under its issued patent #9,091,696 are useful in stimulation of T cell activity. Regen is continuing to develop the NR2F6 program in-house before entering into any potential partnerships.

However, the current patent further modifies T cells to express molecules that act as a localized "danger signal" to the immune system. CAR T cells are T Cells (T lymphocytes) that are genetically engineered to produce chimeric antigen receptors (CARs) on their surface. CARs are proteins that permit the T cells to recognize an antigen on targeted tumor cells.

Regen BioPharma has granted CheckPoint Immunology an exclusive international license to develop and commercialize Regen's NR2F6 technology for human therapeutic use. The objective of the license grant is the separation of Regen BioPharma’s small molecule technology from its other Intellectual Property (IP) to facilitate any future transactions involving small molecule therapies focused on the NR2F6 checkpoint.

Last month, Regen BioPharma, in association with its medicinal chemistry partner, ChemDiv, Inc., announced that it believes it has made a fundamental discovery in developing small molecule drugs that activate NR2F6. It reports that recently identified novel chemical compounds, which activate NR2F6 have key structural elements that make them active and specific.

The NR2F6 nuclear receptor has been identified as a potentially very important immune cell inhibitor (an immune checkpoint) and cancer stem cell differentiator. The NR2F6 program at Regen BioPharma aims to identify antagonists of NR2F6 in an effort to let loose the cancer-killing potential of a patient's own immune system and identifying agonists that should suppress the immune system in diseases where the immune system is over-activated, such as autoimmunity.

Regen BioPharma’s 2018 goal is to develop an activator and inhibitor of NR2F6 that is effective and not toxic in animal models. At that point, the Company will commence experiments and process manufacturing that will enable it to apply for testing these compounds in humans.

Regen BioPharma, Inc. (RGBP), closed Wednesday's trading session at $0.02, even for the day, on 295,057 volume with 22 trades. The average volume for the last 60 days is 133,956 and the stock's 52-week low/high is $0.018/$0.1277.

chart

Alliance BioEnergy Plus, Inc. (ALLM)

Stocks That Move reported earlier on Alliance BioEnergy Plus, Inc. (ALLM), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Alliance BioEnergy Plus, Inc. centers on the commercialization and licensing of a patented cellulose conversion technology. The Company controls this technology through a master license agreement with the University of Central Florida. Alliance BioEnergy Plus’s subsidiaries concentrate on developing technologies in the renewable energy, bio-fuels, and new technologies sectors. Alliance BioEnergy Plus is based in West Palm Beach, Florida.

The Company operates various subsidiaries. AMG Energy Group, LLC owns 50 percent of Carbolosic, LLC (in a joint venture (JV) with Thor Renewable Energy Singapore) and exclusively the territories of North America and Africa. Carbolosic holds the exclusive international license for the patented CTS™ (Cellulose to Sugar) process, developed and owned by the University of Central Florida.

The CTS™ process converts cellulose into commercial grade sugars, fine chemicals, as well as other highly valuable products. Alliance BioEnergy Plus’s intention is to focus on the production of these commercial products through company-owned and licensed facilities.

Alliance’s commercial pilot/demonstration and research facility, Ek Laboratories, LLC, came online in early 2015. Under the direction of CTS™ inventor Dr. Richard Blair, the facility is running the CTS process, at a commercial scale, and is providing licensees with real time analytics.

The AMG Energy Group subsidiary was established to be the technology arm of the Company. AMG focuses on the licensing of Alliance BioEnergy Plus’s Intellectual Property (IP), engineering and construction of CTS plants, and developing technologies in the renewable energy, bio-fuels, and new technology sectors.

The CTS Cellulose Ethanol technology can produce a high quality, clean burning Ethanol from almost any plant material less costly, quicker, and without any hazardous inputs. Alliance BioEnergy Plus has completed the construction of its commercial scale CTS demonstration plant and research laboratories at its subsidiary Central Florida Institute of Science and Technology, Inc. (CFIST).

Alliance BioEnergy Plus has identified high growth potential in the biodegradable plastic market. This market, according to research, will reach $58-65 billion in 2022. It was 19.54 billion in 2016. The Company has the approval and acceptance of the United States Department of Agriculture (USDA) to purchase a closed bioethanol plant.

Alliance BioEnergy Plus has filed an 8K with the SEC (Securities and Exchange Commission) disclosing that its subsidiary Alliance Bio-Products, Inc. entered into a material definitive agreement to buy the closed ethanol facility in Indian River County, Florida. It tendered an initial deposit of $250,000.

The Company received approval from the United States Department of Agriculture (USDA) Office of Rural Development (USDA Rural Development) to move ahead with the purchase in early July. The approved purchase, at a price of $8M, includes the fully functional plant, 144-plus acres that the plant resides on, and all related equipment and vehicles.

Alliance BioEnergy Plus, Inc. (ALLM), closed Wednesday's trading session at $0.0392, up 9.19%, on 70,500 volume with 8 trades. The average volume for the last 60 days is 152,684 and the stock's 52-week low/high is $0.02/$0.31.

chart

Delta International Oil & Gas, Inc. (DLTZ)

Speculating Stocks, OTC Markets, and MarketWatch reported on Delta International Oil & Gas, Inc. (DLTZ), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Delta International Oil & Gas, Inc. is a global, independent oil and gas company specializing in energy. Until recently, the Company’s principal emphasis was on oil and gas exploration in northern Argentina by way of its subsidiary SAHF, LLC. This year, upon an evaluation of the U.S. domestic E&P market, it decided to focus its investments locally. The Company’s investment in MHD Technology Corp. helps extend its reach in the energy field. MHD Technology is a New York company that works to apply its patented technology in MagnetoHydroDynamics to water pipelines in the continental United States. Delta International Oil & Gas is based in Scottsdale, Arizona.

Delta is evaluating prospects for investments in fields other than oil and gas exploration and production. It earlier announced its acquisition of a 10 percent interest in MHD Technology Corp. via its wholly-owned subsidiary Neptune Industries LLC.

MHD Technology is developing a unique water transportation and desalination technology. MHD's next steps are to perform a simulation of its product and then to make the first prototype. Delta's subsidiary, Neptune Industries, will initially be involved in both steps and also in some administrative role.

As of March 31, 2016, Delta, via South American Hedge Fund LLC (SAHF), retained 18 percent of the total concession in the carryover mode (no cost obligations to SAHF) in the Tartagal and Morillo oil and gas concessions in Northern Argentina. Delta doesn’t operate the Tartagal and Morillo concession. It has a minority position in the JV. Furthermore, Delta holds a 30.6 percent interest in the Valle de Lerma concession in Northern Argentina. The JV partners are Grasta SA, PetroNEXUS, High Luck Group, and REMSA.

The properties presently held by SAHF are Tartagal Oriental, Morillo, and Valle de Lerma. SAHF is in the process of selling the Tartagal Oriental and Morillo properties. SAHF is not owned by Delta anymore, but as the sale of Tartagal Oriental and Morillo closes, Delta International Oil & Gas will receive 75 percent of the revenues produced by the transaction (including royalties on the production of the properties). Delta signed an agreement with High Luck for the sale of 18 percent of Tartagal and Morillo. Delta also signed and executed an agreement for the transfer of 100 percent of its interest in SAHF.

Delta International Oil & Gas announced this past August that it closed its first investment in Landmaster Partners, Inc. This investment was done in the form of an 18-month Note with a 9 percent interest and a carried interest in the first two wells.

The intention of the note is to fund the first two re-entry wells that Landmaster has proposed to drill in a Haskell County, Texas property. Landmaster Partners is a Texas-focused oil exploration and production enterprise.

Last month, Delta International Oil & Gas announced that it signed an asset purchase agreement for the acquisition of an oil property in Polk County, Texas from Crestmont Operating, LLC.

With this definitive agreement, Delta acquired a 4-well lease in Polk County, estimated to produce 15-20 barrels of oil per day once a workover is completed on one of the wells.

Delta International Oil & Gas, Inc. (DLTZ), closed Wednesday's trading session at $0.074, up 44.81%, on 10,600 volume with 3 trades. The average volume for the last 60 days is 32,815 and the stock's 52-week low/high is $0.0155/$0.30.

chart

Rainforest Resources, Inc. (RRIF)

High Rising Stocks, Penny Stock Hub, Simply Wall St, Barchart, MarketWatch, Stockhouse, InvestorsHub, 4-Traders, TradingView, YCharts, Wallmine, Stockopedia, Stockflare, Investing News Alerts, Wall Street Pennies, OTC Markets, and WalletInvestor reported on Rainforest Resources, Inc. (RRIF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Rainforest Resources, Inc.’s mission is to protect the ecosystems of the rainforest to reduce the impact of global warming. As part of the Company’s commitment to prevent global warming, it is making the best of efforts to preserve the rainforest, the initial phase being the “Huamboya Forest” Morona Santiago – Ecuador.

Huamboya means Huambu: floating and Ya: house in the old Shuar language. "The house that floats" is inhabited by "SHUAR" communities including the Namakim and Chiguaza that are part of the Sangay National Park located specifically to the South-East of the reserve. At Huamboya, millenary trees and endemic species of the Amazon, terrestrial, aquatic, and aerial are found.

Rainforest Resources has its U.S. office in Anna Maria, Florida. It also has an office in Ecuador and a Singapore representative office. The Company lists on the OTC Markets Group’s OTCQB.

Rainforest Resources incorporated on November 13, 1992 as Innovative Technology Systems, Inc. under the laws of the State of Florida. It changed its name to Amalgamated Gold & Silver, Inc. on March 29, 2012, to reflect a change in the main focus from foreign exchange trading platform developer to gold & silver mining interests in South America and Mexico.

The Company changed its name to Rainforest Resources, Inc. on December 10, 2015 to reflect a change in the main focus from a developer of gold and silver mining interests in South America and Mexico to an environmentally driven natural resources enterprise.

Rainforest Resources is interested in conserving the Huamboya ecosystem. Huamboya presents a Humid Tropical Megathermal climate. The forest is covered by native forest without human intervention.

The Huamboya forest has roughly 586 endemic plant species of which 45 percent are orchids. The forest has a rich diversity of animal life. This includes 343 species of birds, 100 species of mammals, and more than 500 species of vertebrates.

Rainforest Resources operates in the forestry sector. The Company, in its dedication to ease global warming, commits all its efforts and economic support for the conservation of the humid forest. The Company also produces carbon credit certificates and develops and exports natural spring water.

Rainforest Resources’ positions are in tropical rain forests, land for reforestation, and above all clean air. The Company’s vision is to sustain forestry and to live in harmony with forestry in itself.

Rainforest Resources, Inc. (RRIF), closed Wednesday's trading session at $6.45, up 7.50%, on 6,962 volume with 8 trades. The average volume for the last 60 days is 575 and the stock's 52-week low/high is $3.68/$9.45.

chart

MGX Minerals, Inc. (MGXMF)

OTC Markets, Morningstar, 4-Traders, InvestorsHub, Stockhouse, Capital Equity Review, The Street, Stockwatch, The StreetWise Reports, MarketWatch, and Barchart reported on MGX Minerals, Inc. (MGXMF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

MGX Minerals, Inc. is a diversified resource company listed on the OTC Markets’ OTCQB. The Company concentrates on the development of large-scale industrial mineral portfolios in specific commodities and jurisdictions that will fuel the new energy economy. MGX Minerals controls significant interest in lithium, magnesium and silicon assets across North America. The Company has its corporate office in Vancouver, British Columbia.

MGX Minerals has regional control in the majority of industrial mineral projects in the jurisdictions it operates. Regarding near-term potential, MGX focuses on assets that offer streamlined development timelines and low initial capital expenditures.

The Company’s strategy is to identify commodities and jurisdictions where large-scale development opportunities exist. Additionally, its strategy is to build its asset portfolio via aggressive acquisition to quickly build and enhance long-term portfolio value. In addition, its strategy is to engage industry experts to reduce execution risk and quickly increase time to market.

MGX has developed a proprietary, low-energy design process (Rapid Recovery Process), which is patent-pending. The design of it is purposely for highly-mineralized brine associated with oilfields. The process quickly concentrates lithium and other minerals in brine.

Concerning independent confirmation of the Rapid Recovery Process, testing was carried out by a third-party laboratory (Saskatchewan Research Council (SRC)). SRC successfully recovered 83.7 percent of lithium from a representative sample of brine. Lithium was concentrated to 461 ppm from the representative sample containing 71 ppm.

In South America, MGX Minerals has completed pilot plant testing on brine samples originating from numerous salars located in Chile. The Company has entered into a joint brine testing agreement with a number of South American mining companies. The parties are now working to identify potential joint-venture (JV) locations that will employ MGX Minerals’ lithium extraction technology.

Last week, MGX Minerals announced it entered into a Property Option Agreement with Belmont Resources to acquire an initial 25 percent interest in the Kibby Basin, Nevada lithium brine property, roughly 50 km North of Clayton Valley, Nevada.

MGX Minerals will fund up to C$300,000 in exploration expenditures, to be used for drilling in the Kibby Basin. The target area is a large well-defined anomaly discovered by a magnetotelluric survey carried out by Belmont Resources in January of this year. This Agreement allows MGX Minerals to earn an additional 25 percent interest in Kibby Basin property by funding an additional C$300,000 in exploration expenditures for drilling at which time the project will become a 50/50 Joint Venture with access to MGX Minerals’ rapid lithium extraction technology.

Today, MGX Minerals announced the completion of a geotechnical drill program and associated assay results from its Driftwood Creek magnesium project in southeastern British Columbia. The goal of this drill program was to establish pit wall stability and assess static pressure of groundwater using piezometers.

Based on the new results, the Company states that the East Zone appears to have major potential to expand the magnesite mineral zone to the east and north. The West Zone has potential to contain more magnesite with high silica-low calcium content in the north.

MGX Minerals, Inc. (MGXMF), closed Wednesday's trading session at $0.72, up 0.33%, on 301,272 volume with 92 trades. The average volume for the last 60 days is 527,724 and the stock's 52-week low/high is $0.60/$1.5835.

chart

InnerScope Hearing Technologies, Inc. (INND)

Stockhouse, Stockopedia, Front Page Stocks, YCharts, InvestorsHub, and MarketWatch reported on InnerScope Hearing Technologies, Inc. (INND), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

InnerScope Hearing Technologies, Inc. is a technology driven business with highly scalable B2B (Business-to-Business) and B2C (Business-to-Consumer) solutions. It has plans on opening, operating, and expanding a chain of audiological and retail hearing device clinics. InnerScope Hearing Technologies is headquartered in Roseville, California.

InnerScope will compete in the DTC (Direct-to-Consumer) markets with its own line of "Hearables," and "Wearables" and unique Apps on the iOS and Android markets. The Company’s mission is to innovate and deploy products and services on a scalable platform for the 360-plus million people around the Global Suffering from Hearing Impairment to create an Eco-System around InnerScope.

InnerScope Hearing Technologies provides a B2B SaaS (Software as a Service) based Patient Management System (PMS) software program. The design of it is to improve operations and communication with patients. Additionally, InnerScope offers a Buying Group experience for audiology practices. This enables owners to lessen product costs and grow their margins.

InnerScope will create seven separate revenue generating divisions. The Company said that each division will generate revenues and be positioned for growth, thus increasing the Company’s market penetration.

The ALPHA brand product line will be InnerScope’s first products to be registered as Class-1 FDA-Cleared hearing aid medical devices, which will appreciably grow its product portfolio of hearing assistance products and broaden its digital footprint through a multi-direct-to-consumer sales platform.

Recently, InnerScope Hearing Technologies announced it was awarded its FDA importers registration clearances from the FDA for its ALPHA line of hearing aid devices that will sell online via its www.nohasslehearing.com website. InnerScope received, under the FDA code of Federal Regulations, a Class I certificate for its air-conduction hearing aid devices and a Class II certificate for its wireless air-conduction hearing aid devices.

In June, InnerScope Hearing Technologies announced an executed LOI (Letter of Intent) with AlgorKorea Co. Ltd. for an exclusive U.S. and Canada Supply and Distribution License Agreement for AlgorKorea’s patented iNR 64PS2 and iClear SR self-fitting hearing aid devices.

This Agreement will also give InnerScope the exclusive right to freely use AlgorKorea’s seven U.S. patents. The Agreement creates a sales partnership through the year 2021 with an automatic 3-year renewal. The Agreement will permit InnerScope the ability to offer Self-Fitting hearing aid devices Direct-To-Consumer through its www.nohasslehearing.com eCommerce store.

Moreover, in June, InnerScope announced a Supply and Distribution Reseller Agreement with AN Direct US, Inc. for the LifeEar CORE Personalized Smart Hearing Aid Devices. It will add the CORELifeEar to its portfolio product Direct-To-Consumer APP-Based Smart Hearing Aid Device to be sold by way of its eCommerce store.

InnerScope Hearing Technologies, Inc. (INND), closed Wednesday's trading session at $0.0068, even for the day. The average volume for the last 60 days is 357,600 and the stock's 52-week low/high is $0.0056/$1.50.

chart

Accelerize, Inc. (ACLZ)

Buzz Stocks, Greenbackers, ResearchOTC, StockRockandRoll, Planet Penny Stocks, PennyStockProphet, StockOnion, FeedBlitz, Penny Pick Finders, StockOodles, and PennyStockLocks reported previously on Accelerize, Inc. (ACLZ), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Accelerize, Inc. provides marketing technology solutions that transform the way advertisers leverage their digital advertising data. CAKE is a division of Accelerize and is the Company’s digital marketing software division. CAKE provides a cloud-based solution to track and analyze the performance of digital marketing Return on Investment (ROI), in real-time. Accelerize has its corporate headquarters in Newport Beach, California.

CAKE is a software-as-a-service (SaaS) enterprise platform. It provides online tracking, reporting, lead distribution, and analytics solutions for advertisers, online marketers, affiliate marketers, and lead generators. With CAKE, one can track and optimize affiliate traffic. In addition, a user can collect, validate and distribute leads. Furthermore, one can gather and analyze multi-channel data.

Accelerize offers CAKE for Advertisers and CAKE for Networks. CAKE for Advertisers is a SaaS solution. It enables brand advertisers to unify the tracking, attribution, and optimization of digital marketing spend across search, display, email, video, social, affiliate, and other marketing channels.

CAKE for Networks is a marketing solution for affiliate networks. CAKE by Accelerize is headquartered in Newport Beach, with operations in New York, London, India, and Sydney, Australia.

Constructed on CAKE’s Marketing Intelligence platform, Journey is a cloud-based enterprise solution. Journey collects and analyzes customer journey data using multi-touch attribution for marketing campaign optimization.

Last month, Accelerize and its digital marketing software division CAKE announced major momentum in the Asia-Pacific (APAC) region. Revenue and Customer Growth increased by triple digit percentages over a two-year period.

Since establishing itself in important APAC markets in 2015, including India, China, Singapore, Indonesia, Australia and more, CAKE’s revenues in the region have increased by 322 percent, with a 283 percent increase in the number of APAC clients.

Santi Pierini, CAKE President and Chief Operating Officer of Accelerize, said, “International markets represented about 40 percent of our sales overall in 2017, and APAC continues to play an important role in CAKE’s ongoing growth strategy.”

Last week, Accelerize and CAKE announced its growing ecosystem of Connections, alliances with top digital media and marketing tools, which enrich customer journey insights for brands, agencies and publishers. Available to Journey by CAKE users, Connections enable digital marketers to easily extract data from media platforms. With this data, they can rapidly integrate it into a single platform - CAKE’s enterprise SaaS solution.

Accelerize, Inc. (ACLZ), closed Wednesday's trading session at $0.305, down 4.69%, on 17,800 volume with 8 trades. The average volume for the last 60 days is 23,814 and the stock's 52-week low/high is $0.25/$0.40.

chart

International Frontier Resources Corporation (IFRTF)

MarketWatch, Stockhouse, Marketwired, 4-Traders, and Emerging Growth reported on International Frontier Resources Corporation (IFRTF), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

International Frontier Resources Corporation has a demonstrated record of accomplishment advancing oil and gas projects. The Company, by way of its Mexican subsidiary, Petro Frontera S.A.P.I de CV and strategic joint ventures (JVs) is advancing the development of petroleum and natural gas assets in Mexico. International Frontier Resources is based in Calgary, Alberta. The Company lists on the OTC Markets Group’s OTCQB.

International Frontier Resources (IFR) has projects in the U.S. and Canada. This includes the State of Montana and the Northwest Territories.

IFR created a JV company in 2015 - Tonalli Energia - together with Grupo Idesa, one of Mexico’s largest petrochemical companies. IFR and Grupo Idesa are totally aligned; each owns a 50 percent stake in Tonalli. Grupo Idesa is a well-established Mexican petrochemical company.

Block 24 Tecolutla establishes IFR’s Mexican JV as one of the first operators’ in Mexico. In addition, it provides important insights into future rounds. Tecolutla is a very underdeveloped mature field with major upside potential.

The Tecolutla Block is in the Tampico-Misantla Basin within the State of Veracruz. The Tecolutla Field is 7.2 square kilometers. It contains an oil reservoir at 2,340 meters or about 7,700 feet. The Tecolutla Block is a 60-80 m gross pay carbonate reservoir on a structural high with proven oil production.

Tonalli has submitted the regulatory applications and documentation, which will permit IFR to go ahead with the drilling permit and operations at Tecolutla. The expectation is that the existing wells at Tecolutla will exceed historic production numbers and peak initial production (IP) rates with the arrival of new recovering techniques, technology, and expertise to be undertaken by Tonalli.

On May 8, 2018, Tonalli started a production test of the TEC-2 well producing from existing perforations. This well was tested for seven days and recovered an average of 125 barrels of oil per day (bopd).  Last recorded production rate in January 2016 from TEC-2 was 9 bopd and 9 thousand cubic feet (mcf) of natural gas per day.

Over the final day of the test, the TEC-2 well averaged an estimated 105 bopd and 288 mcf of gas producing 514 bbls/d of fluid. Throughout the test, TEC-2 flowed naturally on a restricted 20/64 inch well head choke. A final wellhead flowing pressure was 660 psig.  The ratios of crude oil, water, and natural gas remained consistent throughout the multi-day test.

Yesterday, IFR announced the appointment of a new independent Director, Mr. R. Glenn Dawson to its Board. Mr. Dawson brings 38 years of oil and gas exploration and management experience in the North American hydrocarbon basins to IFR’s Board of Directors. Mr. Dawson has founded a number of publicly traded oil and gas companies. He has been responsible for exploration and production (E&P) budgets of more than CDN$200 million annually.

International Frontier Resources Corporation (IFRTF), closed Wednesday's trading session at $0.1824, up 2.76%, on 57,820 volume with 16 trades. The average volume for the last 60 days is 41,442 and the stock's 52-week low/high is $0.112/$0.2865.

chart

United Cannabis Corp. (CNAB)

PricelessPennyStocks, Stockgoodies, Promotion Stock Secrets, Wealth Insider Alert, Wall Street Mover, Market Intelligence, Marketbeat, StreetAuthority Daily, Actual Gains, Broad Street, TopPennyStockMovers, StocksImpossible, Cannabis Financial Network News, PennyStockRumors, Money Map Press, MyBestStockAlerts, and Wall Street Wolves reported earlier on United Cannabis Corp. (CNAB), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

United Cannabis Corp.’s commitment is to the development of phyto-therapeutic based products supported by patented technologies for the pharmaceutical, medical, and industrial markets. A biotechnology enterprise, the Company established to provide leadership in the medical cannabis industry. This is through providing patient driven solutions intent on improving biomedical and pharmaceutical pursuits using cannabis-based research, products, and services. OTCQB-listed, United Cannabis is headquartered in Denver, Colorado.

United Cannabis provides consulting services, proprietary products, and licenses its intellectual property (IP) to businesses in the cannabis industry. The Company owns distinct IP relating to the legalized growth, production, manufacture, marketing, management, use and distribution of medical and recreational marijuana and marijuana infused products.

United Cannabis is the creator of Prana Bio Nutrient Medicinals. Its A.C.T. Now Program and Prana Bio Nutrient Medicinals provide a comprehensive solution designed to allow physicians and patients to implement and monitor effective therapy protocols.

The A.C.T. Now program provides nutritional recommendations to help patients suffering from chronic pain, opiate dependency, inflammation, glaucoma, PTSD, neuropathy, multiple sclerosis, fibromyalgia, Crohn’s, IBS, seizures, epilepsy, paralysis, autoimmune, autism, tumors, HIV/AIDS, and many types of cancer.

Prana Bio Nutrient Medicinals is a complete, full spectrum cannabinoid system. It uses the whole cannabis plant through controlling specific cannabinoid ratios, accurate dosing, and manifold non-abrasive delivery methods.

United Cannabis has established affiliate relationships with Harborside Health Center of California, Prana Bio Nutrient Medicinals, Bubbleman, Blue River, and Cannabinoid Research & Development (CRD).

United Cannabis has a majority share of Prana Therapeutics, Inc. (PTI). PTI is a clinical stage biotechnology company developing Polymolecular Botanical therapeutics for the oncology, neurology, and orthopaedic markets. Prana Therapeutics focuses on developing targeted therapeutics for the prevention of the negative side effects of chemotherapy, management of rheumatoid arthritis, and treatment of brain cancer.

Last week, United Cannabis announced that the South African Patent Office declared effective the Company's patent application based upon PCT/US2015/056635, and pursuant to the Patent Cooperation Treaty (PCT), for "Cannabis Extracts and Methods of Preparing and Using Same."

United Cannabis’ patent is still in the review process in Australia, Brazil, Canada, China, Colombia, Europe, Eurasia, India, Israel, Japan, Mexico, New Zealand, The Philippines, and South Korea.

United Cannabis Corp. (CNAB), closed Wednesday's trading session at $0.675, up 0.45%, on 209,412 volume with 106 trades. The average volume for the last 60 days is 187,670 and the stock's 52-week low/high is $0.552/$2.50.

chart

The QualityStocks Company Corner

GTX Corp (OTC: GTXOD)

The QualityStocks Daily Newsletter would like to spotlight GTX Corp (GTXOD).

GTX Corp (OTC: GTXOD) terms a confluence of financial events, including its proposed uplisting, reverse split and $1 million in premium-to-market financing from a new strategic partner, as a turning point and milestone for the company’s stakeholders (http://nnw.fm/cZUL9).

GTX Corp (OTC: GTXOD) designs, manufactures and commercializes various products and services in the GPS tracking and monitoring business.  Operating domestically and internationally, via two subsidiaries engaged in the internet of things (IoT) and wearable technology industry. Founded in 2002 and headquartered in Los Angeles, California, the company is a pioneer in Smart GPS, cellular and Bluetooth Low Energy (BLE) tracking technology, offering complete, end-to-end tracking solutions through a proprietary IoT enterprise monitoring platform – the IoT Machine to Machine platform – backed by state-of-the-art hardware, software and connectivity solutions, patents and software algorithms.

Operating under the motto “We Put the ‘Where’ in Wearable Tech,” GTX’s main goal is to keep its customers connected to who and what matters most, with each of its patented tracking technologies providing real-time location coordinates on a map via a personalized portal. The company prides itself on offering not only technologies, but also effective solutions that provide safety, security and peace of mind by helping customers locate their loved ones or lost valuable items.

With a portfolio that includes more than 80 patents filed and issued and with products and services available in 35 countries, GTX’s tracking solutions use the latest in miniaturized, low-power GPS, mobile, RF and BLE technology, that can integrate seamlessly with multiple consumer products, enterprise and military applications. The company became a U.S. Military contractor in 2017 and is already developing asset and human tracking technology for the U.S. Air Force. Its list of customers also includes public health authorities and municipalities, emergency and law enforcement, NGOs, private companies, public and private senior care homes, and consumers.

The company’s flagship product is the award-winning GPS SmartSole®, the world’s first invisible wearable tracking device created specifically for people at risk of wandering, becoming lost or disoriented, including patients with Alzheimer’s, autism, dementia, traumatic brain injury and other cognitive problems. According to the World Alzheimer Report 2013 (http://nnw.fm/mrcV2), there are more than 100 million people worldwide who need constant care and monitoring because of a cognitive disorder, and their number is expected to rise to 277 million by 2050. Due to its hidden location – inside a shoe insert, the device can also be used by people undercover or at risk of kidnapping, such as government agents, military personnel, law enforcement, journalists, corporate executives, etc.

Other tracking devices designed and commercialized by the company for civilian or military use include:

  • Take-Along Tracker 3G: A powerful mini-tracking device with GPS, 2G and 3G GSM data and voice capabilities, as well as a motion sensor and sleep mode. The device can be easily attached to a keychain, lanyard, dog collar, pocket, bag or plush toy for a discreet but advanced tracking solution.
  • Invisabelt: Designed for children, this slim GPS tracker hidden inside a small waistband belt has a battery life of up to two days and is a great solution for parents who want to monitor their children’s location at all times.
  • Track My Workforce: An easy and cost-effective solution that allows businesses to track and monitor their mobile workforce. The app is available for both Android and iOS systems, and allows employers to monitor their workforce from a single company account.
  • E.T.S. -Personnel Equipment Tracking System: Currently in use at the Edwards Air Force Base, this tracking system allows real-time monitoring and surveillance of personnel and assets and has a 200+ square mile coverage. Solar powering capabilities and extend battery life allow the tracker to be used in areas without existing power sources.
  • GPS Rifle Tracker: The company’s smallest GPS tracker, designed to withstand shocks and water submersion due to its robust, military standard enclosure, can be mounted on any AR15 platform picatinny rail to detect weapon discharge, track weapons and inventory, and send time and location alerts.

Led by a management team with solid experience in wearable technology, IoT, consumer electronics, mobile and technology licensing, as well as finance and the footwear industry, GTX plans to leverage its core technology platform to reach new verticals via licensing agreements and strategic partnerships, and to monetize its intellectual property portfolio. The monetization campaign kicked off in 2017 has already identified 100 companies that could become licensees. Besides military and law enforcement, the company also eyes the biometrics market, home health, medicare and insurance and other security applications for potential uses of its IoT platform and tracking technology.

GTX currently has 15 domestic and international distributors, subscribers in 35 countries and more than 700 online affiliates. With multiple revenue streams, several consecutive years of double-digit revenue growth and a strong pipeline of lucrative commercial products, GTX is uniquely positioned to become a leading provider of tracking solutions on this growing multi-billion-dollar market.

GTX Corp (GTXOD), closed the day's trading session at $0.1499, up 47.98%, on 65,809 volume with 27 trades. The average volume for the last 60 days is 551,873 and the stock's 52-week low/high is $0.1013/$0.20.

Recent News

chart

Marijuana Company of America Inc. (OTC: MCOA)

The QualityStocks Daily Newsletter would like to spotlight Marijuana Company of America Inc. (MCOA).

Marijuana Company of America Inc. (OTC: MCOA) is actively engaged in producing all-natural products containing CBD, including a recently released pain cream that can be applied topically to relieve discomfort. Cronos Group, Inc. (NASDAQ: CRON) has recently received a boost in funds and a license to produce cannabis products in Australia, allowing the company to grow its operations.

Marijuana Company of America Inc. (OTC: MCOA) (the “Company”) are pioneers in the cannabis industry going back to 2009 when Don Steinberg, MCOA’s CEO, founded the first marijuana company ever to trade on a U.S. stock market, Medical Marijuana Inc. Since then, Don and his partner, Charlie Larsen, have formed Global Hemp Group and Marijuana Company of America. They have experienced the shift of legislation first hand, not only for the legalization of marijuana but also the emerging hemp-based CBD products.

The CBD market is growing exponentially and consequently the founders of MCOA have constructed their business model around the development of industrial hemp-based CBD products. The industrial hemp plant can be used to produce products that are carbon neutral or even carbon negative. It is one of the longest, strongest natural fibers on earth, used as a building material that is free of mold, pesticide-resistant, and fire proof. Hemp has also been described as a “super food,” which provides additional business opportunities. No part of the plant is left unused and the Company’s overall strategy is to take advantage of every profit center from farm to the multiple valuable finished products.

The cannabis and hemp industries are experiencing unprecedented growth that is expected to continue for many years as these industries are now accepted globally and continue to mature and expand. North American consumers spent $6.7 billion on legal cannabis products in 2016, up 34% from 2015’s $5 billion. This trend is widely expected to explode at a 27% compounded annual growth rate to reach $22.6 billion by 2021, according to ArcView Market Research.

The company offers investors the opportunity to be on the forefront of cannabis and hemp innovation through cultivation, processing in the legal cannabis and industrial hemp sectors. The Company’s business model includes producing a diverse portfolio of synergistic business segments that provide value to its shareholders. Its vertically integrated business model and distribution platforms are positioned to capture market share by developing recognizable and valuable brands.

Under the MCOA umbrella, wholly owned subsidiary hempSMART™, Inc. is committed to bringing high quality CBD-based products to the market through its affiliate marketing program. Through hempSMART, MCOA’s strategic approach to the distribution of products is through a networking architecture geared to maintain customer loyalty and capture market share. The patent-pending product “hempSMART Brain,” is designed to revolutionize the safe and effective support of healthy brain function. The brand new product, HempSMART DROPS, is a full-spectrum CBD tincture formulated with hemp and fractionated coconut oils. The hempSMART marketing team has decades of experience, and is well positioned to take the hempSMART brand to a global audience.

Marijuana Company of America Inc. (MCOA), closed the day's trading session at $0.035, up 11.11%, on 12,527,315 volume with 470 trades. The average volume for the last 60 days is 7,434,505 and the stock's 52-week low/high is $0.022/$0.0728.

Recent News

chart

Koios Beverage Corp. (CSE: KBEV) (OTC: SNOVF)

The QualityStocks Daily Newsletter would like to spotlight Koios Beverage Corp. (SNOVF).

Koios Beverage Corp. (CSE: KBEV) (OTC: SNOVF), is pleased to announce a distribution deal with SportLife Distribution, which will expose the Company's products to thousands of additional retail customers over the next three months.

Koios Beverage Corp. (CSE: KBEV) (OTC: SNOVF) develops and distributes nature-based products that boost brain function, enhance health, and improve productivity. Its core vision is to help a billion people worldwide live more productively through the development of nootropics, which are supplements that improve cognitive abilities.

The company’s flagship product, Koios, is a GMP-certified dietary supplement. Made from natural ingredients and backed by science, Koios is designed to improve focus, memory, mental drive, clarity and energy. The company produces Koios in the following formulations:

  • Powder supplements containing nootropics as well as caffeine and lion’s mane and chaga mushrooms;
  • Vegan-friendly capsules;
  • Canned beverages containing nootropics along with MCT oil to burn fat and increase metabolism.

Not to be mistaken with prescription-only drugs which are at times used for similar effects, nootropics are over-the-counter dietary supplements; some of which, like Koios, contain ingredients that are currently used in the treatment of patients with Alzheimer’s disease. The global field of nootropics is growing rapidly and expected to reach USD $6,059.4 Mn by 2024 with a CAGR of 17.9 percent from 2016 to 2024.

According to media reports, there is believed to be significant and growing use of nootropics among high-achieving students and professionals. The UK’s leading Guardian newspaper found that nootropics are commonly used in Silicon Valley by computer industry professionals who want to “hack” their minds and maximize their productivity without any possible negative effects on the brain.

Koios was born out of the personal struggles of its founder and CEO, Chris Miller, who has ADHD. Miller found that the symptoms of his condition held him back when navigating the competitive modern workplace. Unhappy with the effects of the Adderall he was prescribed, Chris began a search for a natural remedy that would improve his attention and mental capacity.

Speaking of his struggles at this time, Miller says, “Coffee and energy drinks were no longer helping me. Eventually, I was drinking so much caffeine that I was beginning to notice negative and troubling health effects.” He adds, “I believed there had to be a better way. Better technology that the earth was providing that I could implement and not only boost my daily performance but take care of my brain and body long-term.” After years of experiments and with the help of leading scientists, he developed Koios, named after the Greek Titan who represented rational intelligence.

Koios contains the following ingredients, among others:

  • Vitamin B12: Crucial for the function of the nervous system and the synthesis of DNA, B12 also helps in the creation of red blood cells.
  • Vitamin B6: This vitamin is crucial for brain development among children and brain function in adults. B6 is also important in the production of key hormones: serotonin, which regulates mood, norepinephrine, which helps us handle stress, and dopamine.
  • Huperzine A: Developed from the Chinese club moss plant, huperzine A is used on Alzheimer’s patients to boost their memories. It is also used to raise energy levels and alertness and is the subject of medical trials to test its efficacy when combined with other drugs.
  • Bacopa: Also known as brahmi, bacopa is an Indian herb used in Ayurvedic medicine to improve concentration and memory. Modern science has recognized its effectiveness, and it is used to treat symptoms caused by Alzheimer’s disease, ADHD and anxiety.
  • Ciwujia: Sports scientists have been interested in this herb since they heard of how mountain climbers in Tibet use it to boost their performance at high altitudes. Peer-reviewed research has shown that Ciwujia has clear positive effects on endurance.

A full breakdown of Koios’ active ingredients is available on the company website.

Additionally, safety is paramount for Koios, with all its products developed in a high-grade nutraceutical laboratory which is GMP-certified and in compliance with FDA guidelines. Koios only uses high-quality ingredients sourced from the best possible locations in order to deliver a product that is not only safe but also “one of the world’s greatest nootropic blends.”

The company’s products can be found online and in stores, both across the United States and internationally, via a continuously growing distribution network.

Koios CEO Chris Miller is supported by a team with strong credentials in medical supplement start-ups, corporate finance and sales, which includes CFO/Director Anthony Jackson, Director Scott Walters, Director Konstantine Lichtenwald and Vice President of Sales Gina Burrus.

With people seeking a mental edge and cognitive boost, Koios believes that there is an opening in the market for its nature-based, over-the-counter nootropics, especially when current prescription medicines have worrying side effects..

Koios Beverage Corp. (SNOVF), closed the day's trading session at $0.1535, off by 2.23%, on 4,587 volume with 4 trades. The average volume for the last 60 days is 60,688 and the stock's 52-week low/high is $0.001/$0.5121.

Recent News

chart

Lithium Chile Inc. (TSX.V: LITH) (OTCQB: LTMCF)

The QualityStocks Daily Newsletter would like to spotlight Lithium Chile Inc. (LTMCF).

Recent news from the Lithium Triangle shows that Lithium Chile Inc. (TSX.V: LITH) (OTC: LTMCF) is advancing its efforts to produce the precious mineral, which continues to experience demand pressure. The Canadian mining company recently announced that it had received authorization from the Ollagüe (O-YA-GWAY) community to begin an exploration drilling program at its project there, which extends for 3,500 hectares on the Salar de Ollagüe.

Lithium Chile Inc. (TSX.V: LITH) (OTCQB: LTMCF), headquartered in Canada, is advancing one of the largest lithium-rich exploration portfolios in Chile consisting of more than 148,000 hectares covering sections of 13 salars or mineral salt flats and one laguna complex. The company’s wholly owned premier properties include 66 square kilometers on the Salar de Atacama, Chile’s largest mineral salt flat which hosts the world’s highest concentration of lithium brine production and is currently the source of about 35 percent of the world’s lithium production. Lithium Chile also owns a significant copper/gold/silver property portfolio consisting of 28,184 hectares over six different properties.

Lithium Chile’s portfolio in the heart of Chile’s lithium-rich salars includes Salar de Coipasa, Salar de Helados, Salar de Atacama, Salar de Turi Salar de Ollague and Salar de Talar. Surface and near surface salt and brine sampling programs on all properties has been completed. To date, samples of high-grade, near-surface lithium brines at each of these projects are showing excellent chemistry of lithium to potassium and lithium to magnesium ratios. Good chemistry is important as it reduces your overall cost of production. Recent geophysical surveys including T.E.M have been completed on 5 of 6 priority targets and data collected to date has been extremely encouraging.

Lithium Chile has identified multiple high-priority brine target areas at its Atacama and Ollague lithium project areas. These areas display the same geophysical characteristics as the lithium-rich aquifers at Salar de Atacama, home to the world’s largest and highest-grade lithium brine producers. Spanning an area of 1,200 square miles, Salar de Atacama is the world’s third largest salt flat behind Salinas Grandes in Argentina and El Salar de Uyuni in neighboring Bolivia. Exploration drilling and resource definition drilling for these target areas are planned for 2018.

“We are delighted with the discovery of such impressive drill target areas at Atacama and Ollague. The results also follow the recent discovery of a 60km2 target area at another of our top Chilean projects – Helados – where we hope to drill in the second quarter of 2018,” stated President and CEO Steve Cochrane. “We have an aggressive multi-project drill program planned for this year, which includes all three of these exciting projects and we look forward to sharing drill results as they come through.”

Global demand for lithium-ion batteries is expected to surpass US$53 billion by 2024 as governments around the world aggressively seek to ban gas-powered vehicles and major automakers invest billions in new technology and electric vehicles powered by lithium-ion batteries. Chile’s mining-friendly jurisdiction offers Lithium Chile a clear, streamlined permitting process that significantly lowers the cost of lithium production to around $1,800/ton as compared to Australia’s $5,000/ton.

Lithium Chile is led by an experienced team with strong Chilean connections. Cochrane’s 36 years of investment industry experience have primarily been focused on the mining sector. During this time, he raised more than US$500 million for a variety of small cap public companies in various businesses and industry sectors including mining.

Terry Walker, P.Geol., vice president of exploration and chief geologist, is a highly experienced geologist. He has spent over 25 years in Chile’s mining industry and is well connected throughout the sector. Walker is co-founder of GeoServicios Piedra Dorada, an exploration and development services company focused on Latin America. He is a Qualified Person for the North American and Australian stock exchanges.

Lithium Chile is well funded and driven by a top-tier team with more than 100 years of combined experience in financing, mining exploration and development in the natural resources sector.

Lithium Chile Inc. (LTMCF), closed the day's trading session at $0.6245, up 1.04%, on 29,050 volume with 28 trades. The average volume for the last 60 days is 44,100 and the stock's 52-week low/high is $0.535/$0.97.

Recent News

chart

BLOCKStrain Technology Corp. (TSX-V: DNAX)

The QualityStocks Daily Newsletter would like to spotlight BLOCKStrain Technology Corp. (DNAX).

BLOCKSTRAIN TECHNOLOGY CORP. (TSXV: DNAX) is pleased to announce that the Company has entered into a memorandum of understanding dated July 16, 2018 (the "MOU") with Spire Secure Logistics Inc. ("Spire"), a wholly-owned subsidiary of Friday Night Inc. (CSE: TGIF), to introduce and implement the proprietary BLOCKStrain platform to governments throughout Canada, as well as to procure software contracts and commercial agreements with regulatory bodies and licensed producers within the Canadian legal cannabis industry.

BLOCKStrain Technology Corp. (TSX-V: DNAX), a full-service software company headquartered in Vancouver, BC, Canada, has developed the first integrated blockchain platform that registers and tracks cannabis intellectual property (“IP”) from genome to sale. It is proprietary, immutable and cryptographically secure, thereby establishing a single source of truth for cannabis strains and their ownership.

With Canada set to legalize marijuana use for recreational purposes, and other jurisdictions following suit around the world, new challenges will emerge regarding the ability to provide a safe and legal inventory of a product that up until now was largely only available on the black market. Cannabis will be heavily tested and regulated by numerous regulatory bodies in Canada. The cannabis industry faces unique challenges that BLOCKStrain specifically helps it address, including:

  • Mandatory Testing: Through BLOCKStrain’s platform and lab-testing partners, the process is more efficient and streamlined, cutting the administrative burden in half and getting products to market faster;
  • DNA Based Product Validation: The underlying blockchain technology creates a genetic fingerprint that identifies and validates the product electronically so any participant on the platform, including consumers, can view and track what’s happening with that product from genome to sale;
  • Intellectual Property: Third, and perhaps most importantly, the BLOCKStrain platform protects the intellectual property of growers and breeders. This is important for the industry’s growth as products evolve and develop. If a craft grower, for example, creates a popular strain with unique characteristics, it will be able to protect its intellectual property by simply registering the strain’s genome with BLOCKStrain and locking that data into the blockchain. It will reside there forever and will be readily accessible in the event of future disputes, bringing a level of trust to the industry and ensuring licensing fees are paid to all players in the market.

VERIFICATION = CERTIFICATION

BLOCKStrain’s genetics verification process is authentic and incredibly effective. User groups register by creating an account with BLOCKStrain, which starts the process. Organizations and independent growers submit seeds, flower and post-extraction product for testing to a registered and approved testing facility, which then submits test results to BLOCKStrain. Pre-existing data of genetic cannabis strains can also be submitted via BLOCKStrain verification administrators, with those results being added to the user group’s blockchain account. Submissions are entered into BLOCKStrain, and the transaction is completed and recorded.

Each time an item is tested and verified by the network, a Registration Affidavit is auto-generated and given a unique “BLOCKStrain Address” along with a traceable QR Code. Producers, patients and consumers are able to not only verify the test but can also rate the product, write reviews and share opinions. This detail is stored within BLOCKStrain and, just like the test results, cannot be tampered with or modified. Verification and certification are earned by all parties for their participation.

SAFE CONSUMER SUPPLY

BLOCKStrain demystifies the seed-to-sale process for all relevant stakeholders including producers, distributors, shippers, government agencies and consumers by creating a repository of cannabis genomes on an immutable, shared ledger. Thousands of cannabis strains exist and cultivators are breeding new strains all the time. The proliferation of cannabis strains can prove problematic for consumers since there are more than 500 known chemical compounds in a single plant. Furthermore, since several dozens of these compounds have been identified as pharmacologically active, it becomes more and more difficult for consumers to know what they are purchasing.

It is for this reason that being able to quantify the genetics, potency and equivalencies among cannabis products is crucial to the future of legalized cannabis. The difference is not so much in the name or brand attached to the cannabis, but the DNA of the plant itself. BLOCKStrain ensures product integrity, safety, regulatory compliance, product licensing and authenticity – all vital elements for the emerging cannabis industry.  This technology also bolsters the process of meeting government regulatory standards by providing real-time visibility of industry operations to agencies assigned to enforce and regulate cannabis activity.

INTELLECTUAL PROPERTY RIGHTS

BLOCKStrain allows for the defense of intellectual property rights for the grower with an authentic, verifiable chain of evidence embedded in the blockchain itself. Proof of ownership for a specific strain of cannabis is paramount in a multibillion dollar industry. Real life ownership disputes have already begun in the industry with legal battles underway. Unfortunately, the framework for resolving these disputes has yet to be defined and they are not likely to be resolved anytime soon.

Consumers and regulators alike want to know whether a cannabis product grown and sold at a local dispensary is safe and meets quality control standards. BLOCKStrain enhances trust of origin from genome-to-sale as cannabis flows through the supply chain, verifying critical steps in the process such as who is growing the plant, which seed is planted and where did it come from, whether pesticides were used, how much was grown, which tests are used to establish quality and potency, where the product is transported and how, and whether possession limits are meeting regulatory standards.

In summary, BLOCKStrain has developed the most comprehensive, secure and community-driven cannabis genetics archival platform for cannabis breeders and growers, large and small, to protect and release their varieties into the public domain, all while compensating and rewarding them for their contributions.

BLOCKStrain Technology Corp. (DNAX), closed the day's trading session at $0.22, off by 2.22%, on 690,820 volume. The stock's 52-week low/high is $0.105/$1.20.

Recent News

chart

Marifil Mines Ltd. (TSX.V: MFM) (OTCQB: MFMLF)

The QualityStocks Daily Newsletter would like to spotlight Marifil Mines Ltd. (MFMLF).

Marifil Mines (TSX.V: MFM) (OTCQB: MFMLF) is engaged in the exploration, evaluation and acquisition of mineral rich resource properties in Argentina. To view the full article, visit: http://nnw.fm/i4NX0.

Marifil Mines Ltd. (TSX.V: MFM) (OTCQB: MFMLF), headquartered in Vancouver, Canada, is engaged in the exploration, evaluation and acquisition of mineral rich resource properties in Argentina. A rising global demand for cobalt and lithium is generating interest in Marifil Mines and its resources located within South America’s famed “Lithium Triangle,” which include 15,267 hectares spanning its recently acquired Ratones and Fraile claims, as well as two lithium properties covering the southern portions of the Carachi Pampa salar in the Argentine province of Catamarca.

The company’s property also includes the Las Aguilas nickel-copper-cobalt deposit property, with more than four contiguous claims in the San Luis province of Argentina. The Las Aguilas property, which is 100% owned by Marifil, is noted as one of the largest cobalt properties in Argentina. Other noteworthy properties in the company’s portfolio include the Toruel copper-silver property, with more than two contiguous claims, and additional potash properties in Punta Colorada, Pedernal and El Carmen.

Marifil’s sizable portfolio of cobalt and lithium claims in what is recognized as the world’s most prolific mining jurisdiction for these resources strategically positions the company to benefit as global initiatives push demand for lithium-ion batteries toward a frenzy. Zion Market Research, a leading research and consulting firm, has forecast that the lithium-ion battery market could hit $67 billion by 2022, realizing a CAGR of more than 13.7% from 2017-2022. Both lithium and cobalt are major components of these energy storage solutions, with industry data indicating that the battery industry currently consumes roughly 42 percent of global cobalt production.

The company is reviving a lithium exploration program that was active in Argentina a decade ago, building on an unexplored mine it owns there. Marifil will utilize a large proprietary geologic and geochemical data base it developed during its 2009 lithium exploration program in the Salta and Catamarca province sites to resume lithium exploration in the region.

Applications for a second mine and negotiations to purchase a third property are underway, which would establish a significant property portfolio of ‘salar’ brine evaporation lakes. Hydrothermal solutions emanating from regional faults in area volcanoes often enrich the brine with lithium, boron, potassium and magnesium.

In addition to nearly 152,000 acres of lithium-staked properties, Marifil owns 887 acres of land for cobalt exploration and 91,565 acres of gold mining rights in an advanced exploration stage in San Roque that company engineers indicate has high gold discovery potential with “excellent infrastructure and mining friendly politics.”

To date, more than $7.5 million has been invested assessing Marifil’s flagship San Roque gold property, including nearly 16,000 meters of diamond core drilling. The property is jointly owned by Marifil and Novagold Resources, with Marifil holding a 51% stake and serving as the current project operator. The company recently commenced a drilling campaign to further evaluate several deposits of significant gold-silver-indium-lead-zinc mineralization on a 4-kilometer-long zone.

Marifil has closed a private placement funding for $2 million that will inject additional life into the company. Proceeds from the funding will benefit acquisition plans, the ongoing drilling program at Marifil’s gold claim and other output from its general working capital accounts.

Robert Abenante, a chartered professional account, serves as president and chief executive officer of the company. He has extensive experience in the public markets and has served as an officer and director of several public and private companies across various industries, with particular success in the mining sector.

Marifil Mines Ltd. (MFMLF), closed the day's trading session at $0.0974, even for the day. The average volume for the last 60 days is 2,049 and the stock's 52-week low/high is $0.01/$0.165.

Recent News

chart

DeepMarkit Inc. (TSX-V: MKT) (OTCQB: MKTDF)

The QualityStocks Daily Newsletter would like to spotlight DeepMarkit Inc. (MKTDF).

All work and no play may make Jack a dull boy, except when the work of turning online visits into sales becomes delightfully playful with the gamification platform from DeepMarkit Inc. (TSX.V: MKT) (OTCQB: MKTDF). The patent-pending gamification technology company, based in Calgary, Alberta, Canada, is developing ways to increase customer engagement and convert ‘window shoppers’ to buyers by using games.

DeepMarkit Inc. (TSX-V: MKT) (OTCQB: MKTDF), based in Calgary, Alberta, Canada, is a patent pending gamification technology company inventing new ways to engage consumers and other audiences. The Company’s proprietary promotions platform – “Gamify” – enables businesses and agencies to create branded games that incentivize consumers, thus driving sales, capturing data and generating leads. The DeepMarkit platform integrates next-gen gamification engagement mechanics with interactive advertising industry standards and powerful visuals, including 3-D images. Customers may choose from both free and paid solutions suitable for campaigns of all sizes, targeting multiple channels on the web, mobile and social media.

A team of seasoned, passionate gaming executives, led by president and CEO Darold Parken, has worked together for more than 15 years developing games and gaming systems that are still used today by some of the largest gaming companies in the world. This accomplished executive team founded Chartwell Technologies, acquired in 2011 by Amaya Gaming, which now is known as The Stars Group (Nasdaq: TSG) with a market cap of over $5 billion.

Gamify offers a selection of easily customizable gaming apps featuring a customer’s branded e-store in addition to tailored landing pages, technical support, real-time analytics, data collection and an engaging marketing campaign. Gamify’s patent-pending app comes complete with unique user incentives that draw consumers in with games and prizes, which in turn engages shoppers, turning them into buyers and building brand loyalty.

The gamification market is rapidly expanding and projected to be worth $22 billion by 2022, with a CAGR of 41 percent. DeepMarkit is the only publicly listed company focused solely on this exploding market that embraces any size of business, from the mom-and-pop shops to the blue-chip giants. DeepMarkit’s management team knows that increasing a customer’s conversion rate by a mere 1 percent has the potential to double revenue, which is why Gamify’s app and its ability to transform simple shoppers into engaged buyers is so compelling.

“Our marketing platform enables customers to build branded games that incentivize audiences, generate leads, and drive sales. Businesses need a way to stand out from the crowd,” Parken states in an investor’s video (https://www.youtube.com/watch?v=97hJoRKR92k). “DeepMarkit’s gamification platform gives customers that way to stand out and it’s a way that they can afford. That’s the strength of our platform. For a relatively small amount of money, any business can create a very powerful, high quality customer engagement using gamification.”

DeepMarkit recently entered into a joint marketing agreement with ITN International (“ITN”), a global leader in trade show data capture and analytics. The agreement will enable the 1.5 million exhibitors at the 125-plus yearly events serviced by ITN to purchase a customizable campaign with prize delivery and branded games that can be used in collaboration with ITN’s lead retrieval solutions. DeepMarkit and ITN are currently integrating DeepMarkit’s patent-pending gamification platform directly into ITN’s exhibitor portal.

“We started DeepMarkit because we have a passion for games and we believe in the power of games, not just for entertainment but more importantly as a tool for business,” Parken said. “DeepMarkit is a gamification company. What we mean by that is that we create innovative ways to use games for business purposes. Games to generate customer leads, games to promote products, deliver rewards, build brand awareness and customer loyalty.”

Selected as the winner of the New Company/Product pitch competition at the Retail Global 2017 Conference held in Las Vegas, Gamify’s platform has also attracted a $1.5 million investment from Allstate International LLC in Hong Kong. The investment gives Allstate a 10 percent stake in DeepMarkit and a great opportunity to bring the Gamify platform into the burgeoning Asian gaming market.

DeepMarkit Inc. (MKTDF), closed the day's trading session at $0.0373, even for the day. The average volume for the last 60 days is 25,713 and the stock's 52-week low/high is $0.0293/$0.12.

Recent News

chart

Zenosense, Inc. (OTCQB: ZENO)

The QualityStocks Daily Newsletter would like to spotlight Zenosense, Inc. (ZENO).

Through a joint-venture ownership in MIDS Medical Ltd., Zenosense (OTC: ZENO) is developing MIDS Cardiac™, a rapid cardiac diagnostic device. To view the full article, visit: http://nnw.fm/cqX18.

Zenosense, Inc. (OTCQB: ZENO) (the “Company”) is a healthcare technology developer that participates in transformational, disruptive medical diagnostic projects; particularly handheld devices used at the Point of Care which are displacing slow and expensive laboratory tests.

Zenosense is primarily focused on the development and commercialization of MIDS Cardiac™ through the Company’s joint venture ownership in MIDS Medical Limited (“MML”). MIDS Cardiac is in development as a cost-effective, handheld Point of Care (“POC”) diagnostic device and disposable test strip for the early, rapid detection of suspected acute myocardial infarction (“AMI”, or “heart attack”).

Identification of very low levels of cardiac markers can significantly accelerate critical triage, diagnosis, treatment and disposition of patients reporting chest pain. Cardiac troponin is well documented as the preferred biomarker for diagnosis of AMI, with evidence continuing to demonstrate that high sensitivity troponin is the most powerful prognostic biomarker for the assessment of cardiovascular risk in the general population. However, highly sensitive troponin assays are currently available only on state of the art, central laboratory analyzers. These analyzers are extremely expensive, not generally available at the POC and slow to turnaround results (typically 60 minutes) when time is critical.

True, high-sensitivity devices are not available in smaller handheld devices at the POC, where they are most needed. This is because the optical detection systems generally used in central laboratory analyzers cannot be effectively miniaturized.

MIDS Cardiac uses the patented MIDS technology platform, exclusively available to MML. Instead of using conventional optical detection, MIDS can detect and quantify assay beads nano-magnetically. This means it can be incorporated in a small device expected to achieve highly sensitive detection levels, which can support true high sensitivity cardiac biomarker tests in emergency settings, at the POC.

Harnessing world-class expertise, the MML laboratory is located at the prestigious Sci-Tech Daresbury campus in the U.K., internationally recognized for leading-edge, scientific research and commercial development. MML has the sole rights to the MIDS technology platform, which is protected by patent applications already granted in China and the USA, and applications now in the national phase in all other key geographic areas.

MIDS Cardiac aims to provide a single troponin I or T test within 3 minutes and three panel assay (additional cardiac biomarkers) on a disposable test strip within 8 minutes, using a hand-held device costing a fraction of the price of laboratory analyzers.

MIDS Cardiac should only require a pin prick of blood for a single assay test carried out on an easy-to-use, disposable microfluidic test strip. MIDS Cardiac is being designed to be operated quickly by minimally trained personnel, producing a simple to interpret result in emergency settings, even in the back of an ambulance.

Initial testing of the electronic and microfluidic components of the MIDS Cardiac “Hybrid Strip” system was completed in November 2017. The Hybrid Strip system used for development testing aims to replicate as closely as possible a fully integrated Lab on Chip MIDS test strip set-up. Development testing was conducted on both the assembled hybrid unit and its electronic and microfluidic components separately, focusing mainly on the electronics of the magnetic sensing system.

Testing revealed that a variety of brands and sizes of commercially available assay beads could be magnetically detected in very low quantities, including samples of beads that were previously undetectable. In several instances, the current “limit of detection” appeared to already be at or near to the range advised by MML’s assay consultants as suitable for a high sensitivity troponin assay.

Dr. Nasser Djennati, MML’s Managing Director and Chief Scientific Officer, said; “These results come in at the very high end of detection expectations, even at this Hybrid Strip stage. As we move forward into true Lab on Chip construction, I expect detection levels to improve further still.”

Cardiovascular disease is the leading cause of death in the western world, accounting for more than 17 million deaths in Europe and the United States alone. Nearly 20 million patients each year visit an emergency room with reports of chest pain, with hundreds of millions spent on unnecessary admissions to the hospital. Zenosense Inc. is confident MIDS Cardiac will deliver unparalleled levels of accuracy, speed, reliability, ease of use and cost savings, making it the future device of choice for hospitals, emergency rooms, medical practitioners, paramedics and in low-resource settings.

The MIDS technology is also seen as having a far wider application, with the platform being capable of performing Point of Care immunoassay tests for a vast array of common healthcare concerns, a market projected to be worth $23.7 billion per year worldwide by 2019. The medical testing market as a whole is projected to be worth $53.34 billion by 2021. Zenosense believes the MIDS technology could be the most significant advance in diagnostic testing services in decades.

Zenosense, Inc. (ZENO), closed the day's trading session at $0.435, up 1.16%, on 55,498 volume with 28 trades. The average volume for the last 60 days is 270,860 and the stock's 52-week low/high is $0.15/$0.895.

Recent News

chart

Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX)

The QualityStocks Daily Newsletter would like to spotlight Foresight Autonomous Holdings Ltd. (FRSX).

JGR Capital, an independent equity research firm, distributes an update note on Foresight Autonomous (NASDAQ:FRSX), a development-stage technology company that develops powerful and mature proprietary stereoscopic technology. The full report can be found here: bit.ly/2Npo3FH.

Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX), founded in 2015 and headquartered in Israel, is a technological innovator in automotive vision systems and driver assistance technology. Through its wholly owned subsidiary, Foresight Automotive Ltd., Foresight is engaged in the design, development and commercialization of stereo/quad-camera vision systems and V2X cellular-based solutions for the automotive industry based on 3D video analysis, advanced algorithms for image processing and sensor fusion. The company’s powerful and patented stereoscopic technology is derived from field-proven technology that has been deployed throughout the world for almost two decades.

Foresight’s innovative autonomous driving solutions are based on mature, proprietary stereoscopic image technology that uses two synchronized cameras to mimic human depth perception and produce a three-dimensional image. This 3D image can anticipate possible collisions with other vehicles, cyclists, pedestrians and other obstacles. The technology provides highly accurate real-time alerts about the vehicle’s surroundings while in motion. The systems are designed to improve driving safety by enabling highly accurate and reliable threat detection while ensuring the lowest rates of false alerts.

The company’s patents provide IP protection for its robust and proven proprietary stereoscopic technology, which was developed using the security technology of Foresight’s major shareholder, Magna B.S.P.

Foresight has developed three main products:

  • QuadSight™. This breakthrough detection system sets the bar for autonomous vehicle vision. It features nearly 100 percent obstacle detection with almost zero false alerts and operates optimally under all weather and lighting conditions, including darkness, rain, fog, haze and glare. QuadSight™ is the first quad-camera multi-spectral vision solution of its kind, driven by advanced and proven image processing algorithms. The system consists of two sets of stereoscopic infra-red and visible-light cameras that enable highly accurate and reliable obstacle detection for seamless 24/7 vision.
  • Eyes-On™. This solution uses advanced algorithms for accurate depth analysis and obstacle detection to provide a unique stereo vision Advanced Driver Assistance System (ADAS). It can detect all potential obstacles regardless of shape, form or material, including other vehicles, cyclists, pedestrians and animals. It has an accuracy and reliability of almost 100 percent and near zero false alerts.
  • Eye-Net™. This is a cellular-based accident prevention solution that is designed to provide real-time pre-collision alerts to vehicles and pedestrians. This proprietary system is deployed on smartphones and cloud-based servers operating on existing cellular networks, and it eliminates the need for additional designated hardware. Eye-Net™ is designed to provide a complementary layer of protection to advanced driver assistance systems and extends this protection to road users who are not in direct line of sight. It is optimally designed for both urban environments and high-speed scenarios to provide protection for the most vulnerable road users. On March 28, 2018, Foresight announced that it had completed a successful feasibility study of its Eye-Net™ accident prevention solution involving 120 users of Android and iOS cell phones located across Israel.

In 2017, Foresight sought more opportunities within the international market. The Company signed pilot agreements with three leading car manufacturers in China and completed pilot projects meeting all pre-defined requirements and criteria. In addition, FRSX completed a pilot project with Uniti Sweden.

Studies by the Insurance Institute for Highway Safety continue to emphasize the dramatic reduction in accidents and injury-related crashes reported when vehicles are equipped with collision avoidance systems. A recent study by the Institute states that the rate of single-vehicle, sideswipe and head-on crashes was 11 percent lower in vehicles with the warning systems. More importantly, the study shows collision avoidance technology cut the rates of injury crashes of the same type by 21 percent.

Foresight Autonomous Holdings, Inc. also holds a 32 percent interest in RailVision, a company that develops advanced systems for railway safety and maintenance. RailVision has successfully completed 13 tests in Israel, Germany, Italy and Switzerland in addition to a real-time system test with a European railway operator. Over the course of 2017, RailVision successfully completed rounds of financing totaling $5.8 million and started the process of licensing the system according to European standards.

Haim Siboni is the founder of Foresight and has served as the company’s chief executive officer and director since 2015. Siboni, a passionate entrepreneur, has an extensive background in the marketing and business management sectors in the fields of electronics, video, TV, multimedia, computerized systems, line and wireless telecommunication, design and development of systems and devices, including electro-optic radar systems. He is the founder and CEO of Magna B.S.P., Foresight’s major shareholder and a leading innovator in the field of homeland security surveillance solutions.

Foresight Autonomous Holdings Ltd. (FRSX), closed the day's trading session at $3.02, off by 1.46%, on 27,321 volume with 59 trades. The average volume for the last 60 days is 59,447 and the stock's 52-week low/high is $2.44/$9.00.

Recent News

chart

EVIO, Inc. (OTCQB: EVIO)

The QualityStocks Daily Newsletter would like to spotlight EVIO, Inc. (EVIO).

EVIO Inc. (OTCQB: EVIO), a leading provider of cannabis testing and scientific research for the regulated cannabis industry in North America, announced that it will be exhibiting Booth #1113 at the National Cannabis Industry Association's 5th Annual Cannabis Business Summit & Expo coming to San Jose, CA July 25-27, 2018.

EVIO, Inc. (OTCQB: EVIO), via the EVIO Labs division, is the nation’s leading provider of accredited analytical testing, scientific research and advisory services to the regulated cannabis industry. EVIO Labs provides state-mandated ancillary services that are required to ensure the safety and quality of the nation’s cannabis supply. EVIO Labs has performed over 50,000 tests during the past two years and grown from one laboratory in Oregon to nine labs spanning California, Oregon, Colorado, Massachusetts and Florida.

EVIO Labs is driving the cannabis testing industry by providing clients nationwide with consistent high-quality cannabis analytical services backed by quality control assurances. The company also provides advisory services that help cannabis producers and retailers enhance production processes, achieve regulatory compliance and meet quality goals.

EVIO Labs is on track to open 18 laboratories by the end of 2018 at locations around the United States. The Oregon-based company provides analytical services that include testing cannabis and industrial hemp flower, extracts and infused products. The labs specialize in performing the following tests:

  • Cannabinoid analysis, which properly characterizes the many primary cannabinoids found in cannabis including THC, CBD, and several other cannabinoids.
  • Terpene analysis, which identifies the aromatic compounds of the plant (terpene), which can help identify the therapeutic potential of a cannabis flower or extract.
  • Moisture content and water activity, which measure the moisture levels of dried cannabis and are indicators of microbiological growth potential.
  • Pesticide residue analysis of over 100 different pesticides, herbicides, fungicides, growth regulators and other agrochemicals that may be present on cannabis.
  • Detection of harmful residual solvents left behind in the cannabis extract production process.
  • Microbial testing screen for bacterial and fungal contamination in cannabis and cannabis-infused products.
  • Detection of heavy metals including lead, cadmium, mercury, and arsenic.

EVIO Labs is rapidly becoming the nation’s leading cannabis biotechnology company. Led by a management team with extensive experience in designing and rolling out successful business ventures, product research and development, regulatory and compliance protocols, medical cannabis cultivation, production and analytical chemistry techniques, EVIO Labs is prepared to take advantage of today’s fastest growing industry.

EVIO, Inc. (EVIO), closed the day's trading session at $0.97, off by 6.73%, on 105,683 volume with 92 trades. The average volume for the last 60 days is 99,268 and the stock's 52-week low/high is $0.47/$2.70.

Recent News

chart

Net Element (NASDAQ: NETE)

The QualityStocks Daily Newsletter would like to spotlight Net Element (NETE).

Targeting this massive and growing market, Net Element, Inc. (NASDAQ: NETE) has extended its Netevia payment platform to include solutions aimed at sales between vendors, according to a company press release (http://nnw.fm/N3aYc). Also today, NETE was the subject of an updated research note from independent equity research firm JGR Capital. To view the full press release, visit: http://nnw.fm/0I2xb.

Net Element (NETE), is a global financial technology and value-added solutions group that supports electronic payments acceptance in an omni-channel environment spanning across point-of-sale, e-commerce, and mobile devices. Net Element operates a payments-as-a-service transactional model and value-added services platform for small to medium enterprises in the U.S. and selected emerging markets. Internationally, Net Element’s strategy is to leverage its omni-channel platform to deliver flexible offerings to emerging markets with diverse banking, regulatory and demographic conditions. Net Element was ranked as one of the fastest growing companies in North America on Deloitte’s 2017 Technology Fast 500 ™ and South Florida Business Journal’s 2016 fastest growing technology companies.

Net Element believes the future of global commerce is being revolutionized as consumers quickly migrate toward omni-channel shopping utilizing mobile devices, desktop, and online services. Net Element’s all-in-one payment solutions support and unify a whole range of applications through a single, robust platform, allowing global onboarding and support for multiple payment methods.

In a partnership with Bunker Capital, Net Element has also launched a new blockchain-focused business unit that will develop and deploy blockchain technology-based solutions. Net Element expects the new division to create a decentralized crypto-based ecosystem that will act as a framework for an unlimited number of value-added services, connecting merchants and consumers in a seamless, economically efficient transaction. This new business unit intends to also identify and invest in unique projects that decentralize and disrupt the payment processing industry by combining blockchain technology and real-world applications with talented development teams, strong fundamentals and addressable markets large in size.

“We believe that we’re at the dawn of a new evolution where additional digital payment methods are being introduced,” Net Element CEO Oleg Firer, says. “Introduction of our division focused on blockchain as part of the NASDAQ-listed entity will add transparency and compliance assurance to our investors as well as provide access to deploy value-added services to over 20 million electronic commerce clients that are currently part of Net Element’s growing network.”

Net Element clients are treated to customized solutions that provide the flexibility needed to keep up with customers. Among the services offered are mobile payment apps that accept payments anywhere, anytime; cloud-based solutions built to increase productivity and enhance revenue for clients and partners; marketing solutions that turn lookers into buyers; and business analytics that make it easy for clients to monitor business metrics, engage with customers and compare the competition. Its multi-channel platform combines e-commerce, offline, point-of-sale, comprehensive back office tools, mobile point-of-sale, credit scoring and customer interaction in one powerful platform-as-a-service technology.

Net Element owns and operates a global mobile payments and transactional processing provider, TOT Group, Inc., with the following subsidiaries:

  • Unified Payments – An award-winning, customized mobile billing and payments solution, recognized by Inc. Magazine as the No. 1 Fastest Growing Company in America in 2012.
  • Digital Provider – A leading provider of SMS messaging and mobile billing solutions.
  • Aptito – A next-generation, all-in-one, cloud-based restaurant management and point-of-sale payments platform using wireless technology.
  • Payonline – A fully integrated, processor agnostic electronic commerce platform.

Net Element is ranked No. 418 on Deloitte’s 2017 Technology Fast 500™ list of North America’s 500 fastest growing technology, media, telecommunications, life sciences and energy tech companies. Net Element grew 190 percent. The company’s chief executive officer, Oleg Firer, credits the company’s progression to organic growth in its North America Transactions Segment, specifically the success of its Unified Payments brand, which focuses on value-added payment acceptance solutions for small to medium enterprises in the United States.

“The Deloitte 2017 North America Technology Fast 500 winners underscore the impact of technological innovation and world class customer service in driving growth, in a fiercely competitive environment,” said Sandra Shirai, vice chairman, Deloitte Consulting LLP and U.S. technology, media and telecommunications leader. “These companies are on the cutting edge, and are transforming the way we do business.”

Net Element’s suite of application performing interfaces (APIs) and connectors power commerce for businesses of all sizes through multi-channel platforms, all-in-one digital solutions, and end-to-end encryption of cardholder data utilizing tamper resistant hardware that ensures integrity and simplifies security.

Net Element’s corporate team is led by director and CEO Oleg Firer, who is responsible for the overall vision, strategy and execution of the company’s mission of powering global commerce. He is joined by CFO Jonathan New, CPA, and Steven Wolberg, who is the company’s chief legal officer and secretary. Each corporate officer brings a unique blend of leadership, vision, experience and creative energy to the company.

From mobile payments and value-added transactional innovations such as Digital Provider and Aptito to e-commerce and retail payment transaction processing brands like Payonline and United Payments, Net Element is transforming the online and mobile experience.

Net Element (NETE), closed the day's trading session at $7.60, off by 9.09%, on 282,201 volume with 1,092 trades. The average volume for the last 60 days is 161,095 and the stock's 52-week low/high is $2.556/$33.51.

Recent News

chart

Petroteq Energy Inc. (TSX.V: PQE) (OTC: PQEFF)

The QualityStocks Daily Newsletter would like to spotlight Petroteq Energy Inc. (PQEFF).

Petroteq Energy Inc. (TSXV:PQE; OTC:PQEFF; Frankfurt:A2DYWC), a company focused on the development and implementation of proprietary technologies for the energy industry, is pleased to announce its application to the Alternative Energy Development Initiative (AEDI). Also today, it was announced that Petroteq Energy is staying busy as it awaits news about its application to uplist from the OTC Market to the Nasdaq Capital Market.

Petroteq Energy Inc. (TSX.V: PQE) (OTC: PQEFF) is a Canadian-registered, publicly traded company engaged in the development and implementation of proprietary technologies for the environmentally safe extraction of heavy oils from oil sands, oil shale deposits and shallow oil deposits. The company is focused on oil and gas exploration and production on mineral leases it owns in Texas with Accord GR Energy Inc. and in expanding production capacity at its Asphalt Ridge heavy oil extraction facility in Utah.

Petroteq Energy is also participating in a blockchain initiative aimed at solving the global transaction needs of the oil and gas industry through the development of PetroBLOQ, the Company’s collaboration formed with First Bitcoin Capital Corp. (OTC: BITCF). PetroBLOQ’s novel blockchain-based oil and gas supply chain management platform is currently being co-developed by the two companies.

PetroBLOQ recently joined the Enterprise Ethereum Alliance (“EEA”), the world’s largest open-source blockchain initiative. Membership with the 200-member EEA represents a wide variety of industries and offers 14 industry-focused, member-driven working groups.

“Joining this community of forward-looking enterprises and blockchain innovators is an important step for PetroBLOQ as we develop transformative solutions for the oil and gas industry,” said Petroteq Energy CEO Alex Blyumkin.

In addition, Petroteq has joined the American Petroleum Institute (API). The API is the only national trade association representing all facets of the oil and natural gas industry, promoting safety across the industry globally and influencing public policy in support of a strong, viable oil and natural gas industry. “API has led the development of operating standards for our industry, and we look forward to contributing our experience with oilfield technologies in addition to introducing our PetroBLOQ platform to its members throughout the supply chain,” Blyumkin previously stated.

Petroteq Energy’s patent-pending application is a closed-loop, solvent-based process, which results in significantly lower per-barrel production costs than those incurred with traditional hot water-based oil sands extraction technologies. This green technology utilizes a small, modular footprint, produces no greenhouse gases, requires no high temperatures, leaves only clean dry sand, and could be deployed to unlock heavy oil deposits located around the world.

The Company’s Asphalt Ridge mineral lease on 3,000-plus acres in northeastern Utah features a large contingent oil sands resource base with an estimated 87 million barrels of oil equivalent. In 2015, the company produced 10,000 barrels of oil from the Utah location and plans to increase production are underway. Utah holds over 32 billion barrels of undeveloped oil sands resources, which are also known as “oil-wet” deposits containing a mixture of sand and a dense, extremely viscous form of petroleum referred to as bitumen or tar. A recent upswing in developing domestic energy sources has intensified interest in technological advances such as Petroteq’s Liquid Extraction System.

The company’s Texas location includes an ownership interest (46%) in 7,000 acres under mineral leases with Accord, a Houston-based oil and gas exploration company that focuses on the development and recovery of heavy oil reserves and deposits. Two enhanced, licensed oil recovery technologies designed to increase oil recovery from more than 80 shallow oil wells on the property are expected to substantially improve the recovery rates of heavy oil deposits in this area. In both the Utah oil sands and traditional oil patch Texas project, the Company, its subsidiaries and Accord are using proprietary technologies, processes and methodologies to recover heavy oil, providing a distinct, strategic economic advantage for Petroteq Energy and its shareholders.

The Company continues to evaluate the development of other medium to heavy oil exploration, production and recovery projects on a global basis through a variety of structured agreements. These opportunities or other arrangements with private and governmental entities that utilize Petroteq Energy’s proprietary licensed technologies are expected to generate a significant return on investment.

The Company’s management team, board of directors and officers form an invaluable cross-section of industry leaders with extensive experience ranging from chemical engineering and solvent research, business development, international project management, entrepreneurial achievements, and senior management for global energy companies in North America and the Middle East. This impressive knowledge base covers both conventional and unconventional oil and gas projects and production, both in upstream and downstream industry sectors.

Petroteq Energy Inc. (PQEFF), closed the day's trading session at $1.08, up 2.56%, on 667,855 volume with 569 trades. The average volume for the last 60 days is 175,958 and the stock's 52-week low/high is $0.28/$1.8892.

Recent News

chart

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

ActionStockPicksAgressive StocksBetting On Wall StreetCannabisNewsWireGot Stocks?Got Stock Tips?Green Car StocksGreen Energy StocksGreen On The StreetHomeRunStocksMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireQualityStocks MediaQStocksQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsStock BeatsStocks To Buy NowTerrificStocksTiny GemsTip.usTouchdownStocksDaily ToutTraderPower

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.